dc.contributor.author | Bacanak, Merve Saygi | |
dc.date.accessioned | 2021-03-03T14:45:16Z | |
dc.date.available | 2021-03-03T14:45:16Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Bacanak M. S. , "Muscarinic M1 and M2 receptors, fasting and seizure development in animals", CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.8, sa.4, ss.308-313, 2018 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_3b3eae4d-1d89-4b2d-851f-1ac4fc5cd9b6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/43798 | |
dc.description.abstract | Muscarinic M-1 and M-2 receptors are widely distributed in the brain and contribute to various physiological and pathological functions. It is well known that enhancement of cholinergic activity produces convulsions in animals. Pilocarpine, the M-1 muscarinic receptor agonist, is commonly used to induce seizures in rodents. On the other hand it has been reported that fasted rats and mice pretreated with the M-1 and M-2 receptor antagonist atropine, scopolamine or biperiden develop convulsions after food intake indicating cholinergic hypoactivity as the underlying mechanism. This review will present pharmacological data for the M-1 and M-2 receptors in the brain and focus on the contrasting findings related to their contribution to convulsions. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.subject | Klinik Tıp | |
dc.title | Muscarinic M1 and M2 receptors, fasting and seizure development in animals | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND EXPERIMENTAL HEALTH SCIENCES | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 308 | |
dc.identifier.endpage | 313 | |
dc.contributor.firstauthorID | 249399 | |